Details for New Drug Application (NDA): 013174
✉ Email this page to a colleague
NDA 013174 describes DYRENIUM, which is a drug marketed by Concordia and is included in one NDA. It is available from two suppliers. Additional details are available on the DYRENIUM profile page.
The generic ingredient in DYRENIUM is triamterene. There are seventeen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the triamterene profile page.
The generic ingredient in DYRENIUM is triamterene. There are seventeen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the triamterene profile page.
Summary for 013174
| Tradename: | DYRENIUM |
| Applicant: | Concordia |
| Ingredient: | triamterene |
| Patents: | 0 |
Pharmacology for NDA: 013174
| Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Medical Subject Heading (MeSH) Categories for 013174
Suppliers and Packaging for NDA: 013174
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DYRENIUM | triamterene | CAPSULE;ORAL | 013174 | NDA | Concordia Pharmaceuticals Inc. | 59212-002 | 59212-002-01 | 100 CAPSULE in 1 BOTTLE (59212-002-01) |
| DYRENIUM | triamterene | CAPSULE;ORAL | 013174 | NDA | Concordia Pharmaceuticals Inc. | 59212-003 | 59212-003-01 | 100 CAPSULE in 1 BOTTLE (59212-003-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
